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Abstract
Background: Expiratory flow limitation (EFL) is characterised by a markedly reduced expiratory flow insensitive to
the expiratory driving pressure. The presence of EFL can influence the respiratory and cardiovascular function and
damage the small airways; its occurrence has been demonstrated in different diseases, such as COPD, asthma,
obesity, cardiac failure, ARDS, and cystic fibrosis. Our aim was to evaluate the prevalence of EFL in patients requiring
mechanical ventilation for acute respiratory failure and to determine the main clinical characteristics, the risk factors
and clinical outcome associated with the presence of EFL.
Methods: Patients admitted to the intensive care unit (ICU) with an expected length of mechanical ventilation of
72 h were enrolled in this prospective, observational study. Patients were evaluated, within 24 h from ICU admission
and for at least 72 h, in terms of respiratory mechanics, presence of EFL through the PEEP test, daily fluid balance
and followed for outcome measurements.
Results: Among the 121 patients enrolled, 37 (31%) exhibited EFL upon admission. Flow-limited patients had
higher BMI, history of pulmonary or heart disease, worse respiratory dyspnoea score, higher intrinsic positive end-
expiratory pressure, flow and additional resistance. Over the course of the initial 72 h of mechanical ventilation,
additional 21 patients (17%) developed EFL. New onset EFL was associated with a more positive cumulative fluid
balance at day 3 (103.3 ml/kg) compared to that of patients without EFL (65.8 ml/kg). Flow-limited patients had
longer duration of mechanical ventilation, longer ICU length of stay and higher in-ICU mortality.
Conclusions: EFL is common among ICU patients and correlates with adverse outcomes. The major determinant
for developing EFL in patients during the first 3 days of their ICU stay is a positive fluid balance. Further studies are
needed to assess if a restrictive fluid therapy might be associated with a lower incidence of EFL.
Keywords: Respiratory insufficiency, Fluid therapy, Lung disease, Respiratory mechanics, Maximal expiratory flow
rates, Critical care
Background
Expiratory flow limitation (EFL) is a dynamic condition
in which expiratory flow has already reached its maximal
value [1]. According to Mead et al. [2], once the expira-
tory flow is limited at a given lung volume, there is a site
in the intrathoracic airways where intrabronchial and
extrabronchial pressure are equal, the so-called equal
pressure point (EPP) [3]. Airways downstream of the
EPP would be compressed, the diameter markedly
reduced, with the expiratory flow becoming insensitive
to increases of expiratory driving pressure or to the con-
traction of the expiratory muscles [1, 4–7].
Clinically, EFL was demonstrated in patients with
chronic obstructive pulmonary disease (COPD) [4, 8],
acute respiratory distress syndrome (ARDS) [9, 10],
acute and chronic heart failure [11, 12], cystic fibrosis
[13], spinal cord injury [14] and obesity [15]. Recently,
EFL has been described in patients undergoing general
anaesthesia for major abdominal surgery, and its pres-
ence was the best predictors of postoperative pulmonary
complications [16].
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The mechanisms leading to EFL can vary among
different pathologies. COPD patients may develop EFL
because of increased expiratory resistance [17] that tend
to reduce the transmural pressure (i.e. the difference
between the pressure inside and outside the airways),
leading to the development of the EPP. Incomplete lung
emptying is frequently associated with dynamic lung
hyperinflation with the generation of intrinsic positive
end-expiratory pressure (PEEPi) [18]. The latter can
have several adverse effects on haemodynamic (i.e.
cardiac output depression, increased pulmonary vessel
resistance), respiratory muscle function (i.e. altered
length-tension characteristics of the diaphragm, in-
creased work of breathing) and patient-ventilator inter-
action (i.e. patient-ventilator asynchrony). On the other
hand, patients with ARDS [19] or those undergoing gen-
eral anaesthesia [20] can experience a reduction of func-
tional residual capacity (FRC) able both to increase the
expiratory resistance and to favour the collapse of the
small airways. The ensuing inspiration re-open those air-
ways, and repetitive opening and closure of small airways
has been shown to induce histological damage of small air-
ways probably due to the development of high shear forces
[21, 22]. This should elicit an inflammatory response and
increase the risk of low lung volume injury [23, 24].
Although EFL seems to represent a relevant patho-
logical condition, surprisingly, only few studies evaluated
the prevalence of EFL in critically ill patients. Alvisi
et al. [8] demonstrated that almost every COPD patient
(93%) is flow limited at intensive care unit (ICU) admis-
sion for an acute and chronic respiratory failure, while
Koutsoukou et al. [9] found that EFL might be common
in patients with ARDS. However, both studies enrolled a
small number of selected patients so that it is difficult to
derive conclusions on the clinical relevance of EFL and
its determinants.
The primary aim of the present study is to evaluate
the prevalence of EFL in ICU patients requiring mechan-
ical ventilation for acute respiratory failure, and to deter-
mine the main clinical characteristics and risk factors
associated with the presence of EFL. Secondly, we ex-
plored the possible impact of the presence of EFL on pa-
tients’ clinical outcome.
Methods
Design, setting and patients
We performed a prospective, observational study con-
ducted in the general ICU of the S. Anna University
Hospital, Ferrara, Italy. The study was approved by the
ethics committee of our institution (Azienda Ospedaliero-
Universitaria Ferrara Ethic Committee, protocol number:
74/2016). Informed consent was obtained from each
patient or next of kin. Patients were recruited over a 12-
month period between April 2016 and April 2017.
We screened and included all consecutive patients ad-
mitted to the ICU older than 18 years with an acute re-
spiratory failure and with an expected length of
mechanical ventilation of 72 h or more, as judged by the
physician in charge. Exclusion criteria were (1) preg-
nancy, (2) haemodynamic instability (i.e. heart rate ≥ 120
beats/min or cardiac arrhythmia; systolic blood pres-
sure < 90 or vasopressor use, i.e. dopamine or dobuta-
mine ≥ 5 μg/kg/min or noradrenaline ≥ 0.1 μg/kg/min),
(3) presence of laparostomy and (4) active air leakage
(i.e. pneumothorax or presence of thoracic drainage)
(Additional file 1).
The observational period started within 24 h from ad-
mission to ICU and continued for at least 72 h. Patients
were followed for outcome assessment until hospital
discharge.
Determination of EFL and respiratory variables
All measurements were performed by three investigators
(FDC, CR, EM) equally expert in respiratory mechanics
and data collection. Patients were studied in a semi-
recumbent position, with a head of bed angle of 30°.
The presence of EFL was determined by the PEEP test.
The latter is based on a sudden decrease of PEEP from 3
to 0 cmH2O at the end of inspiration in order to in-
crease the expiratory driving pressure and establish
whether or not the expiratory flow increases. If the ex-
piratory flow increases after subtraction of PEEP, then
the patient is classified as not flow limited. On the con-
trary, if the expiratory flow does not increase after sub-
traction of PEEP, the patient is classified as having EFL.
This approach requires a specific manoeuvre to show
two different flow-volume loops in the same display, and
it is available on all modern ventilators. The flow-
volume curve with 3 cmH2O of PEEP is used as a refer-
ence and fixed on the screen. The flow-volume curve of
the ensuing breath in which PEEP is reduced to
0 cmH2O is superimposed to the previous one in order
to determine if the two flow-volume curves overlap (i.e.
the expiratory flow does not increase), or the flow-
volume curve at ZEEP exhibit an increase of the expira-
tory flow (patient not flow limited) (Additional file 2).
The accuracy and the reproducibility of the PEEP test
have been compared to the Negative Expiratory Pressure
(NEP) test and validated previously [20]. Further, the
same PEEP test was used to determine the value of PEEP
able to eliminate the presence of EFL, the so-called
PEEP-EFL. The latter was calculated as the minimal value
of PEEP that, according to the flow-volume curve, allows
the expiratory flow to increase during tidal expiration
(Fig. 1). This was obtained by an incremental PEEP trial.
Respiratory mechanics were performed at zero-PEEP
(ZEEP) by the standard airway occlusion technique using
a 5-s end-expiratory occlusion followed by a 5-s end-
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inspiratory occlusion [20]. The flow and additional re-
sistance as well as the static compliance of the respira-
tory system were computed using standard formulas
[20]. During these tests, patients were deeply sedated
using continuous intravenous infusion of propofol (1–2
mg/kg) and paralysed with a bolus of rocuronium brom-
ide (0.6 mg/kg) and mechanically ventilated in volume-
controlled mode. Patients with COPD were studied after
at least 8 h from the administration of albuterol. As per
our clinical practice, patients without COPD were not
given bronchodilators.
The severity of chronic dyspnoea was rated according
to the modified dyspnoea scale proposed by the Medical
Research Council (mMRC) [25].
Data collection and outcome data
The presence of EFL was determined at the ICU admis-
sion (within 12 h) and daily during the first 72 h. Data of
respiratory mechanics were assessed at day 1 and at day
3 from ICU admission.
Demographics, anthropometrics, comorbidities, infor-
mation and causes of hospitalisation were recorded into
study-specific case report forms and database. COPD
was defined according to recent ATS/ERS criteria [26],
and COPD severity was assessed by the Global Initiative
for COPD (GOLD) criteria [27]. Simplified Acute Physi-
ology Score (SAPS) II and Sequential Organ Failure
Assessment (SOFA) were determined during the first 24 h
after ICU admission. The diagnosis of ARDS was based on
the Berlin definition [28]. The occurrences of acute kidney
injury (AKI) and septic shock were diagnosed according to
international guidelines statements, Kidney Disease: Im-
proving Global Outcomes (KDIGO) criteria [29] and sur-
viving sepsis campaign (Sepsi-3) criteria [30], respectively.
Daily fluid balance was recorded as the algebraic sum
of fluid intake and output per day, not including insens-
ible losses, while cumulative fluid balance (CFB) was
calculated as the algebraic sum of daily fluid balance
during the observational period. We reported CFB as
absolute number or divided by the admission weight of
the patient (CFB/kg). Cumulative fluid overload (CFO)
was calculated by dividing the CFB by the admission
weight of each patient and was expressed as a percent-
age, as previously proposed [31]. We considered a CFO ≥
10% as severe fluid overload.
Fig. 1 Flow-volume curves of a representative patient aimed to
determine the level of PEEP able to eliminate the presence of EFL
(PEEP-EFL). a Until the subtraction of 4 cmH2O of PEEP the
expiratory flow did not increased: the patient was considered flow
limited at 4 cmH2O of PEEP. b Subtraction of 6 cmH2O of PEEP
increased the expiratory flow. c Subtraction of 8 cmH2O increased
the expiratory flow more than after the subtraction of 6 cmH2O of
PEEP. The PEEP-EFL was 5 cmH2O. See text for further explanation
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Outcome data such as days of mechanical ventilation,
ICU and hospital length of stay and ICU and hospital
mortality were retrieved from the hospital’s electronic
patient chart.
Statistical analysis
Data are presented as frequencies and percentages and
mean ± standard deviation or medians with 25th to 75th
percentiles range [interquartile range], depending on the
type of data and their distribution. The Shapiro-Wilk
test was used to assess the assumption of normality.
Categorical data were compared using the χ2 test or
Fisher exact test as appropriate. Unpaired Student’s t
tests or Mann-Whitney U tests for data with normal or
non-normal distribution, respectively, were used to com-
pare continuous variables.
Friedman test was used to test differences in CFB,
CFB/kg and CFO within groups among three different
time points (24 h, 48 h and 72 h from ICU admission).
Kruskal-Wallis test and Mann-Whitney test were used
to test differences in CFB, CFB/kg and CFO between
groups at three different time points (24 h, 48 h and 72 h
from ICU admission). Correlation between CFB/kg and
intrinsic PEEP was assessed by linear regression.
The association between the presence of EFL at admis-
sion and baseline patient characteristics was modelled
using binary logistic regression analysis and reported as
estimated odds ratio (OR) and relative 95% confidence
interval (CI). Patients’ characteristics independently as-
sociated with the presence of EFL at ICU admission
were assessed in a multivariate logistic regression model.
In the same fashion, a univariate logistic approach was
used to assess the association between a CFO ≥ 10%, the
development of AKI in ICU, AHRF, ARDS or septic
shock at admission and the incidence of EFL during the
first 72 h of ICU stay.
Statistical analyses were performed using SPSS 20.0
statistical software (SPSS Inc., Chicago, IL). In all statis-
tical analyses, a 2-tailed test was performed and the p
value ≤ .05 was considered statistically significant.
Results
A total of 121 patients were enrolled, and their main
characteristics at admission are shown in Table 1. The
most frequent causes for ICU admission were acute
hypoxaemic respiratory failure (AHRF) (43%), sepsis
(37%), ARDS (24%) and haemorrhagic shock (9%).
Among the 121 patients included, 28 had a diagnosis of
COPD and 6 of them were admitted for an acute exacer-
bation of COPD.
Occurrence of EFL
Upon admission, 37/121 (31%) patients exhibited EFL,
with a median PEEP-EFL of 8 cmH2O [6–10]. Among
the patients having EFL at admission, 19/37 (51%) had a
diagnosis of COPD. Compared to those without EFL,
flow-limited patients had a higher body mass index
(BMI) (30.7 ± 6.8 vs 25.3 ± 3.9, p < 0.0001) and worse re-
spiratory dyspnoea score [mMRC ≥ 3 26/37 (70%) vs 9/
84 (11%), p < 0.0001]. EFL was more frequently associ-
ated with history of heart disease (28/37 (76%) vs 40/84
(48%), p = 0.004), COPD (19/37 (51%) vs 9/84 (11%), p <
0.0001) and chronic kidney disease (11/37 (30%) vs 10/
84 (12%), p = 0.017). Furthermore, the main factors inde-
pendently related to EFL at ICU admission were a BMI ≥
30 kg/m2 (OR 3.6, 95% CI 1.0–12.6, p = 0.049), a mMRC
score ≥ 3 (OR 8.0, 95% CI 2.3–27.1, p = 0.001), a SOFA
score ≥ 6 (OR 3.6, 95% CI 1.1–12.0, p = 0.036) and a
medical history of COPD (OR 4.7, 95% CI 1.5–14.4, p =
0.008) (Table 2).
During the first 72 h of ICU stay, 21 additional pa-
tients (17%) developed EFL. Specifically, 13 patients
(11%) became flow limited after 48 h and 8 (7%) after 72
h. Their clinical characteristics are reported in Add-
itional file 2. Of note, they exhibited a BMI similar to
the one of patients without EFL and the diagnosis of
COPD (Additional file 3). Finally, patients becoming
flow limited during the ICU stay exhibited values of
PEEP-EFL statistically lower than those with EFL at ICU
admission (Additional file 4).
Data of respiratory mechanics
At the ICU admission, patients with EFL exhibited
higher PEEPi (7 [4–10] vs 2 [1–2] cmH2O, p < 0.0001),
total airways resistance (22 [17–26] vs 16 [13–21]
cmH2O/l/s p < 0.0001) and additional resistance (10 [6–
14] vs 7 [5–10] cmH2O/l/s, p = 0.001) (Table 3). These
differences remained constant during the ICU stay, be-
ing detected also at 72 h after ICU admission (Table 3).
Of note, data of respiratory mechanics of patients devel-
oping EFL during the ICU stay were not different from
those obtained in the absence of EFL (Additional file 5).
Cumulative fluid balance and EFL development
Patients who developed EFL during the first 72 h of ICU
stay had a higher cumulative fluid balance and cumulative
fluid overload compared to patients without EFL and with
EFL at ICU admission. The trend of cumulative fluid ac-
cumulation is shown in Fig. 2 and in Additional file 6.
In patients developing EFL during the ICU stay, a
higher cumulative fluid balance was associated with
higher values of intrinsic PEEP on the day of EFL devel-
opment (R2 = 0.304, p = 0.010) (Fig. 3).
Moreover, a CFO ≥ 10% over the first 2 and 3 days of
ICU stay was associated with the development of EFL
over the first 3 days of stay in ICU (OR 3.9, 95% CI 1.4–
10.9, p = 0.011 and OR 3.1 95% CI 1.1–8.5, p = 0.030, re-
spectively) (Table 4).
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Outcomes
Overall, patients who had EFL at admission and developed
EFL over the first 72 h of ICU stay were ventilated for a
longer time (9 [5–15] vs 7 [3–14] days, p = 0.043) and had
a longer ICU length of stay (14 [10–19] vs 10 [6–17] days,
p = 0.034) and higher ICU mortality (17/58 (29%) vs 9/63
(14%), p = 0.044) compared to those without EFL.
Patients who developed EFL during the first 3 days of
ICU stay were not ventilated for a longer time (8 [3–15]
vs 7 [3–14] days, p = 0.448) and had no longer ICU
length of stay (14 [8–18] vs 10 [6–17] days, p = 0.344)
and higher ICU mortality (5/21 (24%) vs 9/63 (14%), p =
0.310) compared to patients who never developed EFL.
Discussion
The main results of the present study can be sum-
marised as follows: (1) EFL is frequent among ICU
patients requiring mechanical ventilation for acute re-
spiratory failure of different origin; (2) patients exhibit-
ing EFL have worse parameters of respiratory mechanics
and clinical outcome compared to those who did not;
(3) the absence of EFL at ICU admission does not ex-
clude its occurrence during ICU stay since part of the
patients (17%) developed EFL after ICU admission; and
(4) the development of EFL during the ICU stay was
strongly associated with a positive fluid balance.
The presence of EFL was previously detected in 93%
of the COPD patients at ICU admission [8], and their
pathophysiological pulmonary characteristics explain
why they are prone to develop EFL compared to other
categories of patients. However, the presence of EFL has
been previously demonstrated in other patients so that it
could be hypothesised that an unknown amount of ICU
patients other than COPD can exhibit EFL. This could
Table 1 Clinical and demographic characteristics of the patients at ICU admission
Variables Total (n = 121) NO EFL (n = 84) EFL (n = 37) p value
Age 68 ± 14 67 ± 15 71 ± 12 0.181
Male sex, n (%) 81 (67) 60 (71) 21 (57) 0.114
BMI, kg/m2 27.0 ± 5.6 25.3 ± 3.9 30.7 ± 6.8 < 0.0001
SOFA at admission 6 [4–9] 6 [4–8] 8 [6–10] 0.015
SAPSII 42 [31–48] 38 [29–47] 42 [35–53] 0.077
Smoking history, n (%) 0.343
Current smoker 29 (24) 17 (20) 12 (32)
Former smoker 31 (26) 16 (25) 15 (26)
mMRC ≥ 3 35 (29) 9 (11) 26 (70) < 0.0001
NYHA ≥ 2 62 (51) 27 (32) 35 (95) < 0.0001
Comorbidities, n (%)
Heart diseases 68 (56) 40 (48) 28 (76) 0.004
Hypertension 42 (35) 28 (33) 14 (38) 0.632
Chronic cardiac ischaemia 43 (36) 22 (26) 21 (57) 0.001
COPD 28 (23) 9 (11) 19 (51) < 0.0001
OSAS 7 (6) 3 (4) 4 (11) 0.116
CKD 21 (17) 10 (12) 11 (30) 0.017
Reason for MV initiation, n (%)
AHRF 52 (43) 31 (37) 21 (57) 0.042
Sepsis 45 (37) 34 (41) 11 (30) 0.260
Septic shock 28 (23) 21 (25) 7 (19) 0.465
Haemorrhagic shock 11 (9) 8 (10) 3 (8) 0.803
Coma 13 (11) 11 (13) 2 (5) 0.208
ARDS 29 (24) 13 (16) 16 (43) 0.001
Mild 7 (24) 3 (23) 4 (24)
Moderate 14 (48) 8 (62) 6 (38)
Severe 8 (28) 2 (15) 6 (38)
EFL expiratory flow limitation, BMI body mass index, SOFA Sequential Organ Failure Assessment, SAPS II Simplified Acute Physiology Score, mMRC modified
Medical Research Council dyspnoea scale, NYHA New York Heart Association classification, COPD chronic obstructive pulmonary disease, OSAS obstructive sleep
apnoea syndrome, CKD chronic kidney disease, ICU intensive care unit, AHRF acute hypoxaemic respiratory failure, ARDS acute respiratory distress syndrome
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Table 2 Association between baseline characteristics of patients and the presence of EFL at ICU admission according to logistic
regression analysis adjusted for potential confounders
Variables Univariate analysis Multivariate analysis
Crude odds ratio 95% CI p value Adjusted odds ratio 95% CI p value
BMI (ref: < 30 kg/m2)
≥ 30 kg/m2 7.0 2.8–17.3 < 0.0001 3.6 1.0–12.6 0.049
mMRC (ref: < 3)
≥ 3 19.7 7.3–52.8 < 0.0001 8.0 2.3–27.1 0.001
COPD (ref: absence)
Presence 8.8 3.4–22.6 < 0.0001 4.6 1.4–15.3 0.008
Heart disease (ref: absence)
Presence 3.7 1.6–8.3 0.002 1.6 0.5–5.0 0.418
CKD (ref: absence)
Presence 3.1 1.2–8.2 0.021 1.7 0.4–6.7 0.470
SOFA score (ref: < 7)
≥ 6 3.0 1.2–7.3 0.016 3.6 1.1–12.0 0.036
OSAS (ref: absence)
Presence 3.3 0.7–15.4 0.134
Age (ref: < 70)
≥ 70 0.9 0.5–2.1 0.968
Smoking history (ref: non-smoker)
Actual smoker 1.8 0.7–4.6 0.203
Past smoker 0.9 0.3–2.4 0.834
SAPS II (ref: < 41)
≥ 42 1.7 0.7–3.7 0.188
BMI body mass index, mMRC modified Medical Research Council scale for dyspnoea, COPD chronic obstructive pulmonary disease, CKD chronic kidney disease,
OSAS obstructive sleep apnoea syndrome, SOFA Sequential Organ Failure Assessment, SAPS Simplified Acute Physiology Score
Table 3 Data of respiratory mechanics at day 1 and day 3 after ICU admission
Variables Day 1 Day 3
NO EFL (n = 84) EFL (n = 37) p value NO EFL (n = 63) EFL (n = 58) p value
Cst,rs, ml/cmH2O 49 [40–64] 47 [38–56] 0.309 48 [39–61] 52 [39–56] 0.652
Rrs,max, cmH2O/l/s 16 [13–21] 22 [17–26] < 0.0001 17 [15–20] 21 [17–27] 0.031
Rrs,min, cmH2O/l/s 8 [6–12] 9 [7–13] 0.269 9 [7–13] 9 [7–14] 0.825
ΔRrs, cmH2O/l/s 7 [5–10] 10 [6–14] 0.001 7 [5–10] 11 [6–14] 0.008
P/F ratio 257 [177–370] 168 [123–260] 0.003 230 [170–329] 183 [134–265] < 0.0001
PEEPi, cmH2O 2 [1–2] 7 [4–10] < 0.0001 1 [0–2] 6 [4–9] < 0.0001
PEEPappl, cmH2O 7 [6–8] 10 [8–12] < 0.0001 8 [6–10] 10 [8–12] < 0.0001
RR, breaths/min 15 [14–18] 15 [14–16] 0.839 15 [14–17] 16 [15–20] 0.065
VT, ml/kg IBW 7.3 [6.7–7.3] 8.0 [7.0–8.9] 0.098 7.2 [6.4–8.0] 7.3 [6.1–7.9] 0.673
Ppeak, cmH2O 20 [17–24] 27 [24–31] < 0.0001 21 [17–25] 29 [22–33] < 0.0001
Pplat, cmH2O 17 [15–19] 19 [16–18] 0.009 17 [15–20] 19 [15–21] 0.227
ΔP, cmH2O 9 [8–12] 11 [8–13] 0.268 9 [8–12] 9 [7–12] 0.741
EFL expiratory flow limitation, Cst,rs static compliance of the respiratory system, Rrs,max total resistance of the respiratory system, Rrs,min flow resistance of the
respiratory system, ΔRrs additional resistance of the respiratory system, P/F arterial partial oxygen pressure to fraction of inspired oxygen ratio, PEEPi intrinsic
positive end-expiratory pressure, PEEP appl positive end-expiratory pressure applied at the ventilator, RR respiratory rate, VT tidal volume, IBW ideal body weight,
Ppeak peak inspiratory pressure, Pplat plateau pressure, ΔP driving pressure
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have relevant clinical consequences since the presence of
EFL has numerous side effects [1], such as the presence
of PEEPi [32] that might have detrimental effects on re-
spiratory efficiency and cardiovascular function. Further,
the reduction of the expiratory flow and the inability to
increase it by the expiratory muscle contraction decrease
the efficacy of cough and secretion removal [14] favour-
ing the development of atelectasis, bronchitis and pneu-
monia. Finally, EFL might imply cyclic opening/closure
of the small airways [7, 33] that can lead to hypoxaemia
and ventilation/perfusion mismatch.
Interestingly, a large amount of the patients enrolled
in the present study (48%) were flow limited within the
first 72 h of ICU stay, suggesting that EFL is common in
ICU patients. Patients with EFL had higher duration of
mechanical ventilation, ICU length of stay and ICU mor-
tality. These outcomes were associated with a more
compromised respiratory function since these patients
Fig. 2 Cumulative fluid balance over the first 3 days of ICU stay. Patients who developed expiratory flow limitation (EFL) after ICU admission
(blue) had higher cumulative fluid balances compared to those flow limited at admission (violet), and those who never developed EFL (red)
Fig. 3 Correlation between CFB and values of PEEPi in patients developing EFL after the ICU admission. The correlation was determined the day
the patients became flow limited
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exhibited increased inspiratory and additional resistance
and higher PEEPi.
However, our study shows another complementary as-
pect that deserves clinical attention. We were surprised
that 21 patients (17%) became flow limited after ICU ad-
mission. While it is easily explainable that obese patients
or those with COPD or heart disease can exhibit EFL at
ICU admission, it could be less clear why patients might
develop EFL during the ICU stay. Interestingly, the main
determinant of EFL after ICU admission was a positive
fluid balance. Patients who developed EFL during the
first 72 h of ICU stay had the higher cumulative fluid
overload (Table 4 and Fig. 2); further, a CFO ≥ 10% over
the first 2 days of ICU stay was independently associated
with EFL (OR 3.7, 95%CI 1.2–11.4, p = 0.025).
Hence, fluid therapy can have relevant clinical conse-
quences even at the lung level. Physician should pay par-
ticular attention to the amount of fluid administered.
Excessive fluids administration can lead to EFL. The lat-
ter has been demonstrated to be responsible of damage
of small airways that elicit an inflammatory response
[22, 23]. It was previously demonstrated that a positive
fluid balance can worsen respiratory function, increase
the occurrence of pulmonary complication and have an
impact on patients’ outcome in patients with acute lung
injury and ARDS [34–36].
Detecting and abolishing EFL should be part of the
lung-protective strategy. Ventilation at low lung volume
leading to EFL could be avoided by the use of PEEP. In
patients with flow limited at the ICU admission, the
value of PEEP able to avoid EFL was 8 [6–10] cmH2O
and then statistically decreased to 6 [5–8] at day 3, while
in those developing EFL during the ICU stay, this value
was 5 [5–6] cmH2O at day 1 and 5 [4–7] at day 3. The
effects of PEEP on EFL have been previously tested in
patients with ARDS. Koutsoukou et al. [37] demon-
strated that 10 cmH2O of PEEP abolished the presence
of EFL during tidal ventilation. The difference between
the two studies could be the patients’ population, the se-
verity of the underlying disease and the number of pa-
tients enrolled. Koutsoukou et al. [37] studied 13
patients while we enrolled 121 patients with ARF of dif-
ferent aetiologies.
The present study has some limitations: (1) it is a
single-centre design with limited sample size. However,
this is the first study aiming at identifying possible
causes of EFL occurrence in an unselected cohort of
ventilated patients; (2) we did not use other techniques
such as extra-vascular lung water measurement or lung
ultrasound to quantify lung oedema for confirming the
association between cumulative fluid overload and EFL
occurrence; (3) application of the PEEP test, as it is for
all tests evaluating the presence of EFL, carries the need
of having the patients for one breath at ZEEP. This
could partially derecruit the lung, although the limited
time on ZEEP ventilation should minimise the possible
effects of the PEEP test on lung function; and (4) we
have reported some data on the association between EFL
prevalence/development and ICU mortality. However,
these data should be regarded only as descriptive since
the observational nature of this study and the small sam-
ple size do not allow us to make any conclusion. Future
larger studies are needed to prove the potential effect of
EFL development on the increase of ICU mortality.
Conclusions
The presence of EFL is common among ICU patients re-
quiring mechanical ventilation for acute respiratory failure
of different aetiologies. Interestingly, the major determin-
ant for developing EFL in patients during the first 3 days
of their ICU stay is a positive fluid balance. Further studies
are needed to assess if a restrictive fluid therapy might be
associated with a lower incidence of EFL.
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